Market Cap 360.85M
Revenue (ttm) 22.27M
Net Income (ttm) -40.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -181.72%
Debt to Equity Ratio 0.00
Volume 1,375,400
Avg Vol 2,830,736
Day's Range N/A - N/A
Shares Out 45.68M
Stochastic %K 62%
Beta 0.59
Analysts Strong Sell
Price Target $20.60

Company Profile

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 727 1755
Address:
10865 Road to the Cure, Suite 150, San Diego, United States
MadMusk
MadMusk Aug. 5 at 2:41 PM
$VYNE $REPL $CAPR $SRPT Vyne is another biotech that failed and has huge amount of cash cash to market cap 8:1. Almost Zero debt. About to explode in coming weeks
1 · Reply
DaveTradesLIVE
DaveTradesLIVE Aug. 5 at 2:28 PM
$CAPR 🚨potential exists for a fairly quick gap fill on 1 hr tf down at 6.74 within the next wk or so. Will be quickly bought up into latter half of Aug to take us to 16.4 target level. All dips near 7-8$ are heavily discounted buy opportunities.
0 · Reply
CAPRfanBoy
CAPRfanBoy Aug. 5 at 2:19 PM
0 · Reply
Fishbanger51
Fishbanger51 Aug. 5 at 2:13 PM
$CAPR type a meeting path forward coming next
0 · Reply
Notquiteabillionaire
Notquiteabillionaire Aug. 5 at 1:52 PM
$CAPR Trump talking Pharma tariffs again. CAPR Deramiocel safe and Made in US. Get with the program FDA. 🙄
2 · Reply
laurenlee
laurenlee Aug. 5 at 1:41 PM
$CAPR The funds are buying Why?
2 · Reply
smacsJHI
smacsJHI Aug. 5 at 1:38 PM
$CAPR Couple headwinds for pharma that is going to hold us back this week. Tarriff talk from Trump and the heating up conversation of Prasad coming back. I do not see any world where Prasad comes back but the market generally sells down and asks questions later
2 · Reply
Stormfury66
Stormfury66 Aug. 5 at 1:37 PM
$CAPR Listen NOBODY knows anything for sure with the FDA tango . Just know this “KNOW WHAT YOU OWN & in the not so distant future all investors will be rewarded .. FDA approval will come , exactly what date TBA . Patience my friends silence is golden for now .. one day you will wake up to GREAT news . Long & strong
1 · Reply
laurenlee
laurenlee Aug. 5 at 1:06 PM
$CAPR he threw in a few bones too
0 · Reply
laurenlee
laurenlee Aug. 5 at 1:05 PM
$CAPR we are waiting
0 · Reply
Latest News on CAPR
Capricor's Lead Duchenne Therapy Hits FDA Regulatory Roadblock

Jul 11, 2025, 9:03 AM EDT - 25 days ago

Capricor's Lead Duchenne Therapy Hits FDA Regulatory Roadblock


US FDA declines to approve Capricor's muscle disorder therapy

Jul 11, 2025, 6:36 AM EDT - 25 days ago

US FDA declines to approve Capricor's muscle disorder therapy


Why Is Capricor Therapeutics Stock Trading Lower On Monday?

Jun 23, 2025, 12:46 PM EDT - 6 weeks ago

Why Is Capricor Therapeutics Stock Trading Lower On Monday?


Capricor Therapeutics' Buy Thesis Ahead Of Deramiocel PDUFA Date

May 23, 2025, 2:44 AM EDT - 2 months ago

Capricor Therapeutics' Buy Thesis Ahead Of Deramiocel PDUFA Date


MadMusk
MadMusk Aug. 5 at 2:41 PM
$VYNE $REPL $CAPR $SRPT Vyne is another biotech that failed and has huge amount of cash cash to market cap 8:1. Almost Zero debt. About to explode in coming weeks
1 · Reply
DaveTradesLIVE
DaveTradesLIVE Aug. 5 at 2:28 PM
$CAPR 🚨potential exists for a fairly quick gap fill on 1 hr tf down at 6.74 within the next wk or so. Will be quickly bought up into latter half of Aug to take us to 16.4 target level. All dips near 7-8$ are heavily discounted buy opportunities.
0 · Reply
CAPRfanBoy
CAPRfanBoy Aug. 5 at 2:19 PM
0 · Reply
Fishbanger51
Fishbanger51 Aug. 5 at 2:13 PM
$CAPR type a meeting path forward coming next
0 · Reply
Notquiteabillionaire
Notquiteabillionaire Aug. 5 at 1:52 PM
$CAPR Trump talking Pharma tariffs again. CAPR Deramiocel safe and Made in US. Get with the program FDA. 🙄
2 · Reply
laurenlee
laurenlee Aug. 5 at 1:41 PM
$CAPR The funds are buying Why?
2 · Reply
smacsJHI
smacsJHI Aug. 5 at 1:38 PM
$CAPR Couple headwinds for pharma that is going to hold us back this week. Tarriff talk from Trump and the heating up conversation of Prasad coming back. I do not see any world where Prasad comes back but the market generally sells down and asks questions later
2 · Reply
Stormfury66
Stormfury66 Aug. 5 at 1:37 PM
$CAPR Listen NOBODY knows anything for sure with the FDA tango . Just know this “KNOW WHAT YOU OWN & in the not so distant future all investors will be rewarded .. FDA approval will come , exactly what date TBA . Patience my friends silence is golden for now .. one day you will wake up to GREAT news . Long & strong
1 · Reply
laurenlee
laurenlee Aug. 5 at 1:06 PM
$CAPR he threw in a few bones too
0 · Reply
laurenlee
laurenlee Aug. 5 at 1:05 PM
$CAPR we are waiting
0 · Reply
laurenlee
laurenlee Aug. 5 at 12:55 PM
2 · Reply
laurenlee
laurenlee Aug. 5 at 12:54 PM
$CAPR Remarkable buys
1 · Reply
laurenlee
laurenlee Aug. 5 at 12:53 PM
0 · Reply
laurenlee
laurenlee Aug. 5 at 12:47 PM
$CAPR H O D L
0 · Reply
rogertrades
rogertrades Aug. 5 at 12:47 PM
$CAPR at $7.50 they'll pay about 7500 puts but will burn about 15000 calls.
3 · Reply
laurenlee
laurenlee Aug. 5 at 12:36 PM
$CAPR HOLY MOLY NEW NEW NRW NEW NEW NEW
1 · Reply
rogertrades
rogertrades Aug. 5 at 12:17 PM
$CAPR my chart says mkts setting up for large sell event later this week into all next week going into opex. For Capricor, they'll do their best to hold us around $7.50 strike? Unsure. If we don't breach up $7.90 close from last Friday, things may not look so hot in short term. General mkt madness continues. Eg PLTR beat revenue by $60M and that was enough to propel the stock by another $19B in market cap on top of yesterday’s 4% gain in anticipation of earnings. Chasing 100 times price to sales is the in thing apparently
2 · Reply
NeLoWtF_
NeLoWtF_ Aug. 5 at 11:55 AM
$CAPR What a stock grab from minority shareholders! The 13f increase in recent weeks is quite remarkable. As I understand it, the Type A meeting should take place before August 12th, but this FDA is unpredictable, or the CAPR isn't telling us anything, and legally, until they have the official minutes, they can remain silent. Linda has done this before, and several times. There will be a public meeting today or this week for the ER next week; it's very likely. But I would love for the Type A meeting to take place before the ER. We'll see the results of the SRPT and its powerful influence, something Linda would have to learn: that science alone is not valid when there is no 100% cure for the disease. These days promise to be fun, at least on this forum, with so much nonsense, some of it mine, haha.
0 · Reply
NeLoWtF_
NeLoWtF_ Aug. 5 at 11:43 AM
$CAPR 2025-08-04 13F Pier Capital, LLC 367,717 added
3 · Reply
Publicola29
Publicola29 Aug. 5 at 11:37 AM
$CAPR uh oh https://www.morningstar.com/news/pr-newswire/20250803dc42986/capr-investors-have-opportunity-to-lead-capricor-therapeutics-inc-securities-fraud-lawsuit
1 · Reply
ZR92x
ZR92x Aug. 5 at 11:21 AM
$CAPR Unfortunately I think they are setting the stage for Prasad to return in some capacity even if not head of CBER
1 · Reply
Parsnip
Parsnip Aug. 5 at 11:09 AM
$CAPR One thing is absolutely certain here is that the big money has a mole at the FDA costing shareholders billions of dollars. If the tide changes at the FDA the big money will know before we do. Sit tight and let them do what they do, it’s part of the illegal system and there’s nothing we can do about it .
2 · Reply